Marc Rio
Impact in
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
Papers in
-
- Pulmonary Hypertension Research and Treatments 4
- Co-authors
- Pierre Chambon (2 shared papers)Jean‐Pierre Bellocq (2 shared papers)Ulla Rasmussen (2 shared papers)Gervaise Loirand (11 shared papers)C. Koehl (2 shared papers)B Gairard (2 shared papers)R Rénaud (2 shared papers)H Caldéroli (1 shared paper)
- Journals
- British Journal of Pharmacology (2 papers)Hypertension (2 papers)Proceedings of the National Academy of Sciences (2 papers)The FASEB Journal (1 paper)Gene (1 paper)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Marc Rio
25 papers receiving 892 citations
Peers
Comparison fields: 5 of 77
- Oncology 220
- Cancer Research 107
- Genetics 167
- Molecular Biology 380
- Aquatic Science 35
Countries citing papers authored by Marc Rio
This map shows the geographic impact of Marc Rio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Rio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Rio more than expected).
Fields of papers citing papers by Marc Rio
This network shows the impact of papers produced by Marc Rio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Rio. The network helps show where Marc Rio may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Rio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 255 | |
| 2 | pS2 expression and response to hormonal therapy in patients with advanced breast cancer. | 1991 | 110 |
| 3 | 2009 | 104 | |
| 4 | Identification of a new interferon-alpha-inducible gene (p27) on human chromosome 14q32 and its expression in breast carcinoma. | 1993 | 86 |
| 5 | 2000 | 82 | |
| 6 | 2011 | 64 | |
| 7 | 2013 | 45 | |
| 8 | 1999 | 41 | |
| 9 | 2017 | 40 | |
| 10 | 2017 | 17 | |
| 11 | 2022 | 16 | |
| 12 | Expression of an estrogen-induced breast cancer-associated protein (pS2) in benign and malignant human ovarian cysts. | 1994 | 14 |
| 13 | 1995 | 12 | |
| 14 | 2022 | 10 | |
| 15 | 2007 | 7 | |
| 16 | 2006 | 4 | |
| 17 | 2006 | 3 | |
| 18 | 2002 | 3 | |
| 19 | 1982 | 2 | |
| 20 | [Infarction of the anterior spinal artery and primary antiphospholipid syndrome]. | 2009 | 2 |
About Marc Rio
Marc Rio is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Genetics and Cancer Research, having authored 25 papers that have together received 922 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (4 papers), Estrogen and related hormone effects (4 papers), Cancer, Lipids, and Metabolism (2 papers), Cancer-related Molecular Pathways (2 papers), HER2/EGFR in Cancer Research (2 papers), Cellular Mechanics and Interactions (2 papers), Cell Adhesion Molecules Research (2 papers) and Advanced Proteomics Techniques and Applications (1 paper). The work is most often cited by research in Oncology (220 citations), Cancer Research (107 citations), Genetics (167 citations), Molecular Biology (380 citations) and Aquatic Science (35 citations). Marc Rio has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Pierre Chambon, Jean‐Pierre Bellocq, Ulla Rasmussen, Gervaise Loirand, C. Koehl, B Gairard, R Rénaud, H Caldéroli, A. Krust and Pierre Pacaud. Their work appears in journals such as British Journal of Pharmacology, Hypertension, Proceedings of the National Academy of Sciences, The FASEB Journal and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.